Human medicines European public assessment report (EPAR): Chenodeoxycholic acid Leadiant (previously known as Chenodeoxycholic acid sigma-tau), chenodeoxycholic acid, Xanthomatosis, Cerebrotendinous;Metabolism, Inborn Errors, Date of authorisation: 10/04

Human medicines European public assessment report (EPAR): Chenodeoxycholic acid Leadiant (previously known as Chenodeoxycholic acid sigma-tau), chenodeoxycholic acid, Xanthomatosis, Cerebrotendinous;Metabolism, Inborn Errors, Date of authorisation: 10/04/2017, Revision: 6, Status: Authorised